20190516: ICC NF186 and NF140 IgG in CIDP patients

Objective: To test CIDP patients for IgG positivity towards NF140 and 186.

Samples: 19-061, 19-163, 19-164, 19-165, 19-166, 19-167, 19-168, 19-169, 19-170, negative control, positive control (LAC).

ICC NF155:

  • Transfection date: 2019.05.09
  • Blocking solution: 5% goat serum in PBS.
  • Patient’s sera diluted 1/100 for IgG with 5% goat serum in PBS.
  • Primary antibody: AF3235 diluted 1/1000.
  • Secondary antibodies: GAC488 + GAH 594 IgG (1/1000).
  • Vectashield mounting medium.

RESULTS: All patients were negative except for patient 19-061, with a mild positivity for NF140 and NF186 (also + in NF155). We are going to perform an ELISA.

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.